Data / Form D filings / DBV Technologies S.A.
DBV Technologies S.A.: Form D filing
DBV Technologies S.A., a pharmaceuticals company in Chatillon, France, filed a Form D with the SEC in 2025. The latest, on April 17, 2025, reports $306.9 million sold of a $306.9 million offering to 14 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 107 AVENUE DE LA REPUBLIQUE, Chatillon, France, 92320
- Phone
- 33(0)155427878
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- France
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1613780
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 17, 2025 | New notice | $306,900,000 | $306,900,000 | 14 | Apr 7, 2025 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Mailys Ferrere | Director | |
| Ravi Madduri Rao | Director | |
| Daniele Guyot-Caparros | Director | |
| Pharis Mohideen | Executive Officer | |
| Daniel Soland | Director | |
| Adora Ndu | Director | |
| Julie O'Neill | Director | |
| Daniel Tasse | Executive Officer, Director | |
| Virginie Boucinha | Executive Officer | |
| Michel de Rosen | Director | |
| Timothy E. Morris | Director | |
| Michael Goller | Director |
Every Form D from the week of Apr 14, 2025 · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what DBV Technologies S.A. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.